These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 24424197)

  • 1. Diagnosis and classification of neuromyelitis optica (Devic's syndrome).
    Drori T; Chapman J
    Autoimmun Rev; 2014; 13(4-5):531-3. PubMed ID: 24424197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Devic's index case: A critical reappraisal - AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis?
    Jarius S; Wildemann B
    J Neurol Sci; 2019 Dec; 407():116396. PubMed ID: 31726278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic neuritis in neuromyelitis optica.
    Levin MH; Bennett JL; Verkman AS
    Prog Retin Eye Res; 2013 Sep; 36():159-71. PubMed ID: 23545439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
    Lana-Peixoto MA; Callegaro D
    Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica: clinical features, immunopathogenesis and treatment.
    Jarius S; Wildemann B; Paul F
    Clin Exp Immunol; 2014 May; 176(2):149-64. PubMed ID: 24666204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
    Jacob A; McKeon A; Nakashima I; Sato DK; Elsone L; Fujihara K; de Seze J
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):922-30. PubMed ID: 23142960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica (Devic's syndrome).
    Wingerchuk DM; Weinshenker BG
    Handb Clin Neurol; 2014; 122():581-99. PubMed ID: 24507536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of neuromyelitis optica.
    Levy M; Wildemann B; Jarius S; Orellano B; Sasidharan S; Weber MS; Stuve O
    Adv Immunol; 2014; 121():213-42. PubMed ID: 24388217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
    Crout TM; Parks LP; Majithia V
    Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
    Juryńczyk M; Weinshenker B; Akman-Demir G; Asgari N; Barnes D; Boggild M; Chaudhuri A; D'hooghe M; Evangelou N; Geraldes R; Illes Z; Jacob A; Kim HJ; Kleiter I; Levy M; Marignier R; McGuigan C; Murray K; Nakashima I; Pandit L; Paul F; Pittock S; Selmaj K; de Sèze J; Siva A; Tanasescu R; Vukusic S; Wingerchuk D; Wren D; Leite I; Palace J
    J Neurol; 2016 Jan; 263(1):140-9. PubMed ID: 26530512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
    Asgari N; Skejø HP; Lillevang ST; Stenager E
    Ugeskr Laeger; 2013 May; 175(19):1331-5. PubMed ID: 23663369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Devic's neuromyelitis optica: diagnosis after 10 years of bilateral severe relapsing optic neuritis].
    Déral-Stéphant V; Roux-Lelièvre C; Vignal R; Stéphant E; Faivre A; Alla P
    J Fr Ophtalmol; 2008 Sep; 31(7):705-9. PubMed ID: 18971856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).
    Asgari N
    Dan Med J; 2013 Oct; 60(10):B4730. PubMed ID: 24083534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].
    Jordan B; Eger K; Kornhuber ME; Zierz S
    Fortschr Neurol Psychiatr; 2008 Jan; 76(1):21-7. PubMed ID: 18189220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rare Variant of Neuromyelitis Optica.
    Choudhury A; Chakraborty A; Bhattacharyya AK
    J Assoc Physicians India; 2018 Oct; 66(10):86-87. PubMed ID: 31317719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.